|
| 產地 | 進口、國產 |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS11256 |
| 應用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-SNX5 |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Mitoferrin 2 |
全、新、優(yōu)、品、好四大特點：
分選連接蛋白5抗體說明書 全：公司提供上萬種產品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產品在我司都能找到。
新：產品更新速度較快，基本上每周都有新產品出現(xiàn)。
優(yōu)：產品質量好，投訴比較少。
好：我公司具有優(yōu)質的技術團隊，產品一旦售出，實驗過程中遇到困難可提供在線技術咨詢。使您使用產品時沒有任何的后顧之憂。
分選連接蛋白5抗體說明書 英文名稱 Anti-SNX5
中文名稱 分選連接蛋白5抗體說明書
別 名 0910001N05Rik; 1810032P22Rik; AU019504; D2Ertd52e; FLJ10931; OTTHUMP00000030340; OTTHUMP00000062927; OTTMUSP00000003367; OTTMUSP00000003368; RP11-504H3.2; RP23-35E16.2; snoRNA MBI-43; SNX 5; SNX5; SNX5_HUMAN; Sorting nexin 5; Sorting nexin-5.
產品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep
產品類型 一抗
研究領域 細胞生物 信號轉導 生長因子和激素 轉錄調節(jié)因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 47kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from Human SNX5 (2-75aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
分選連接蛋白5抗體說明書 產品應用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介紹 Sorting nexin 1 (SNX1) is a member of a large family of hydrophilic proteins that interact with a variety of receptor types and are involved in intracellular trafficking (1). SNX1 and the related splice variant, SNX1A, bind the epidermal growth factor (EGF) receptor, facilitate its transport to lysosome, and thereby contribute to the degradation of the receptor (2,3). SNX2 and SNX4 share a high degree of amino acid similarity with SNX1, as they all contain a characteristic phox homology (PX) domain (4). These proteins are all partially associated with cellular membranes, and they, likewise, associate with EGF, PDGF and insulin receptor tyrosine kinases (2). These nexins are widely expressed and yet have various tissue distribution patterns. Additionally, the sorting nexins can associate with each other and with a variety of other cellular proteins, suggesting that they exist as part of multisubunit complexes (1,5). The related protein, SNX3, comprises a distinct subgroup of nexins that share less sequence similarity outside of the PX domain and have dramatically different binding affinities for the tyrosine kinase receptors (2,6).
Function : May be involved in several stages of intracellular trafficking. Plays a role in macropinocytosis. Plays a role in the internalization of EGFR after EGF stimulation.
Subunit : Interacts with SNX1; this promotes location at the endosome membrane.
Subcellular Location : Early endosome membrane; Peripheral membrane protein; Cytoplasmic side. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm. Cell projection, phagocytic cup. Cell projection, ruffle. Note=Recruited to the plasma membrane after EGF stimulation, which leads to increased levels of phosphatidylinositol 3,4-bisphosphate (PdtIns(3,4)P2). Detected on macropinosomes. Targeted to membrane ruffles in response to EGFR stimulation.
Similarity : Belongs to the sorting nexin family.
Contains 1 BAR domain.
Contains 1 PX (phox homology) domain.
Database links : UniProtKB/Swiss-Prot: Q9Y5X3.1
實驗流程：
正在熱銷的相關產品：
Neurocan 神經粘蛋白抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-ATH III 凝血酶Ⅲ抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-AXL (Tyr698+Tyr702+Tyr703) 磷酸化粘附相關激酶抗體 規(guī)格 0.1ml
山羊抗大鼠 IgG(H+L)/Biotin 0.1ml 美國Jackson公司分裝
VAT1 英文名稱： 嗜鉻顆粒胺轉運蛋白VAT1抗體 0.1ml
DAP12 英文名稱： 自然殺傷激活受體相關蛋白DAP12抗體 0.1ml
Anti-ATH III 凝血酶Ⅲ抗體Multi-class antibodies規(guī)格： 0.2ml
Anti-phospho-MK1/MAPKK1(pSer298)/FITC 熒光素標記抗磷酸化原活化蛋白激酶激酶1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rabbit Anti-Goat IgG 兔抗羊IgG (親和層析純化)Multi-class antibodies規(guī)格： 1mg
下游轉錄因子Gli1蛋白抗體 Anti-GLI1 0.2ml
Rabbit Anti-Bov IgG/PE-Cy5.5 PE-Cy5.5標記的兔抗IgG 0.1ml
FAM13B1 英文名稱： FAM13B1蛋白抗體 0.2ml
Rhesus antibody Rh Phospho-SHP2/SHIP2(Tyr81) 磷酸化蛋白酪氨酸磷酸酶2抗體 規(guī)格 0.1ml
Rabbit Anti-Goat IgG 兔抗羊IgG (親和層析純化)Multi-class antibodies規(guī)格： 1mg
14-3-3 family protein 英文名稱： 蘋果14-3-3蛋白抗體(植物) 1ml
EIF5 英文名稱： 真核翻譯起始因子5抗體 0.2ml
轉甲狀腺素蛋白抗體 Anti-Transthyretin 0.2ml
Anti-TRAF3/CD40bp /FITC 熒光素標記CD40結合蛋白/CD40受體相關因子1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh phospho-IRS1(Thr176) 磷酸化受體底物1抗體 規(guī)格 0.1ml
PTP-1B (Protein-tyrosine phosphatase, non-receptor ) 蛋白酪氨酸磷酸酶-1B(抗原)Multi-class antibodies規(guī)格： 0.5mg
A549, 人細胞系
Lec1 倉鼠卵巢細胞
CD82 Others Human 人 CD82 人細胞裂解液 (陽性對照)
CM-H035人腸內皮細胞完全培養(yǎng)基100mL
人周細胞HBVP
人卵巢腺癌細胞;SK-OV-3 大鼠肺微內皮細胞完全培養(yǎng)基 100mL
C57小鼠瘤株;ME (Me)
OLR1 Others Human 人 OLR1 / LOX1 人細胞裂解液 (陽性對照)
CaEs-17 人細胞
GBC-SD人細胞 GBC-SD cells in human gallbladder carcinomas RPMI-1640(GIBCO)+10%FBS
LEFTY2 Protein Human 重組人 Lefty2 / Lefty A 蛋白 (Fc 標簽)
人肝內膽管上皮細胞 (HIBEC)( 5×105 ) HSC-T6, 大鼠肝星狀細胞系 Rattus
分選連接蛋白5抗體說明書 A549, 人細胞系
Lec1 倉鼠卵巢細胞
CD82 Others Human 人 CD82 人細胞裂解液 (陽性對照)
CM-H035人腸內皮細胞完全培養(yǎng)基100mL
人周細胞HBVP
人卵巢腺癌細胞;SK-OV-3 大鼠肺微內皮細胞完全培養(yǎng)基 100mL
技術外包服務:
★分選連接蛋白5抗體說明書 分子生物學：質粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構建等
★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構建、細胞RNAi技術等等。
